Cyprus
2006: Reimbursement of anti-dementia drugs
The availability of medicines in general
In Cyprus, medicines are provided by hospitals or institutions. Drugs prescribed are included in an approved list. Patients are required to pay 50% of the costs of treatments on the approved list.[1]
The availability of Alzheimer treatments
All anti-dementia drugs are available in Cyprus and are part of the reimbursement system. Alzheimer Europe was unable to obtain detailed information on reimbursement restrictions in Cyprus.
| Rivastigmine | Galantamine | Memantine |
||
| Reimbursement | Yes | Yes | Yes | Yes |
| Initial treatment decision | No information | No information | No information | No information |
| Continuing treatment decision | No information | No information | No information | No information |
| Required examinations | No information | No information | No information | No information |
| MMSE limits | No information | No information | No information | No information |
| People living alone | No information | No information | No information | No information |
| People in nursing homes | No information | No information | No information | No information |
[1] European Commission (2006): MISSOC – Mutual information system on social protection : Social protection in the Member States of the European Union, of the European Economic Area and in Switzerland : Comparative tables
Last Updated: Wednesday 15 July 2009
